Centre for Rheumatology Research, Division of Medicine, University College London, 46 Cleveland Street, London W1T4JF, United Kingdom.
Curr Opin Immunol. 2010 Dec;22(6):761-7. doi: 10.1016/j.coi.2010.10.009. Epub 2010 Nov 17.
Compelling evidence has demonstrated that IL-10-producing regulatory B cells (B(regs)) are specialized to suppress immune responses and control various immunopathologies. Several reports have provided information on the phenotype, generation, and mechanism of action of B(regs). Recent work has also identified B(regs) in humans and has begun to unravel their phenotype and mode of suppression. A complete analysis of their function in immune-mediated diseases is required for possible future use of B(regs) as a part of new clinical strategies for treating autoimmune diseases and in the induction of transplant tolerance.
大量证据表明,产生白细胞介素-10 的调节性 B 细胞(Breg)是专门用来抑制免疫反应和控制各种免疫病理的。有几项研究报告提供了有关 Breg 的表型、生成和作用机制的信息。最近的工作还在人类中鉴定出了 Breg,并开始揭示其表型和抑制模式。为了将来可能将 Breg 作为治疗自身免疫性疾病和诱导移植耐受的新临床策略的一部分加以利用,需要对它们在免疫介导性疾病中的功能进行全面分析。